TCHD D/B/A JPS HEALTH NETWORK
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $4.8M
- Transactions
- 618
- Companies
- 40
- Average per transaction
- $7,695
Who reported the payments
| Biotissue Holdings Inc. | $619,694 |
| AstraZeneca | $535,168 |
| Pfizer | $456,689 |
| Novartis | $434,598 |
| AbbVie | $413,916 |
| Smith+Nephew | $388,052 |
| Eli Lilly | $226,847 |
| Endo Pharmaceuticals Inc. | $206,473 |
| Boehringer Ingelheim | $202,153 |
| CSL Behring | $170,027 |
| E.r. Squibb & Sons, L.L.C. | $149,397 |
| Genentech, Inc. | $133,979 |
| Axogen | $96,571 |
| Hoffmann-la Roche Limited | $82,150 |
| Galvanize Therapeutics, Inc | $73,002 |
| Angiodynamics, Inc. | $71,833 |
| Medical Device Business Services, Inc. | $71,217 |
| Merck | $69,664 |
| Integra Lifesciences Corporation | $58,637 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | $49,259 |
| KARL Storz Endoscopy-america | $43,115 |
| Bristol Myers Squibb | $41,164 |
| Tanabe Pharma America, Inc. | $28,854 |
| Alkermes, Inc. | $19,113 |
| Kls-martin L.p. | $15,228 |
| Stryker | $14,674 |
| Novocure GmbH | $13,650 |
| Osiris Therapeutics Inc. | $11,449 |
| Avita Medical Americas, LLC | $11,000 |
| Abbott | $10,112 |
| Carter Bloodcare | $8,950 |
| Mallinckrodt Hospital Products Inc. | $6,000 |
| Zimmer Biomet | $5,871 |
| B. Braun Medical Inc. | $4,713 |
| Johnson & Johnson | $3,849 |
| Mindray DS USA, Inc. | $2,137 |
| Organon | $1,400 |
| Daiichi Sankyo Inc. | $1,242 |
| Incyte Corporation | $950 |
| Fisher Scientific Company L.L.C. | $860 |